Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance

Marc R Dweck, Sanjiv Joshi, Timothy Murigu, Ankur Gulati, Francisco Alpendurada, Andrew Jabbour, Alicia Maceira, Isabelle Roussin, David B Northridge, Philip J Kilner, Stuart A Cook, Nicholas A Boon, John Pepper, Raad H Mohiaddin, David E Newby, Dudley J Pennell, Sanjay K Prasad, Marc R Dweck, Sanjiv Joshi, Timothy Murigu, Ankur Gulati, Francisco Alpendurada, Andrew Jabbour, Alicia Maceira, Isabelle Roussin, David B Northridge, Philip J Kilner, Stuart A Cook, Nicholas A Boon, John Pepper, Raad H Mohiaddin, David E Newby, Dudley J Pennell, Sanjay K Prasad

Abstract

Background: Cardiovascular magnetic resonance (CMR) is the gold standard non-invasive method for determining left ventricular (LV) mass and volume but has not been used previously to characterise the LV remodeling response in aortic stenosis. We sought to investigate the degree and patterns of hypertrophy in aortic stenosis using CMR.

Methods: Patients with moderate or severe aortic stenosis, normal coronary arteries and no other significant valve lesions or cardiomyopathy were scanned by CMR with valve severity assessed by planimetry and velocity mapping. The extent and patterns of hypertrophy were investigated using measurements of the LV mass index, indexed LV volumes and the LV mass/volume ratio. Asymmetric forms of remodeling and hypertrophy were defined by a regional wall thickening ≥ 13 mm and >1.5-fold the thickness of the opposing myocardial segment.

Results: Ninety-one patients (61 ± 21 years; 57 male) with aortic stenosis (aortic valve area 0.93 ± 0.32 cm2) were recruited. The severity of aortic stenosis was unrelated to the degree (r2=0.012, P=0.43) and pattern (P=0.22) of hypertrophy. By univariate analysis, only male sex demonstrated an association with LV mass index (P=0.02). Six patterns of LV adaption were observed: normal ventricular geometry (n=11), concentric remodeling (n=11), asymmetric remodeling (n=11), concentric hypertrophy (n=34), asymmetric hypertrophy (n=14) and LV decompensation (n=10). Asymmetric patterns displayed considerable overlap in appearances (wall thickness 17 ± 2mm) with hypertrophic cardiomyopathy.

Conclusions: We have demonstrated that in patients with moderate and severe aortic stenosis, the pattern of LV adaption and degree of hypertrophy do not closely correlate with the severity of valve narrowing and that asymmetric patterns of wall thickening are common.

Trial registration: ClinicalTrials.gov NCT00930735.

Figures

Figure 1
Figure 1
CMR definitions of the six patterns of left ventricular hypertrophy and remodeling in aortic stenosis. Schematic representation of the left ventricular structure alongside CMR short-axis images of the left ventricle in end-diastole. Normal ventricular structure: characterised by a normal LV mass index, indexed LVEDV, and a normal M/V. Concentric remodeling: characterised by an increased M/V and normal LV mass index. Asymmetric remodeling: similar to concentric remodeling except that in addition there is evidence of asymmetric wall thickening. Concentric Hypertrophy: characterised by an increased M/V and LV mass index. Asymmetric hypertrophy: similar to concentric hypertrophy except that in addition there is evidence of asymmetric wall thickening.Left Ventricular Decompensation: characterised by a dilated left ventricle and normal M/V. The LV mass index may be increased primarily due to LV dilatation. Note no patients fulfilled the criteria for eccentric hypertrophy and so this was replaced by LV decompensation. ↑increased; ↓decreased; = normal; ✓present; ✖absent.
Figure 2
Figure 2
Lack of correlation between aortic valve area and left ventricular mass index.A. Total population. B. Population after excluding patients with hypertension. C. Males. D. Females.
Figure 3
Figure 3
Site of maximal wall thickening in asymmetric hypertrophy and remodeling based on the 17-segment model of the left ventricle. Asymmetric wall thickening was observed in the basal anterior wall in 7%, otherwise it was confined to the septum at the basal and mid-cavity levels.

References

    1. Carabello BA. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease. J Heart Valve Dis. 1995;4(Suppl 2):S132–S138. discussion S138–139.
    1. Grossman W, Jones D, McLaurin L. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56–64. doi: 10.1172/JCI108079.
    1. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis. 2006;48:326–341. doi: 10.1016/j.pcad.2006.02.001.
    1. Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl. 2005;23:S27–S33. doi: 10.1097/01.hjh.0000165625.79933.9a.
    1. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E, de Simone G. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart. 2011;97:301–307. doi: 10.1136/hrt.2010.192997.
    1. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550–1558. doi: 10.1016/0735-1097(92)90617-V.
    1. Cioffi G, Stefenelli C. Comparison of left ventricular geometry and left atrial size and function in patients with aortic stenosis versus those with pure aortic regurgitation. Am J Cardiol. 2002;90:601–606. doi: 10.1016/S0002-9149(02)02563-8.
    1. Hess OM, Schneider J, Turina M, Carroll JD, Rothlin M, Krayenbuehl HP. Asymmetric septal hypertrophy in patients with aortic stenosis: an adaptive mechanism or a coexistence of hypertrophic cardiomyopathy? J Am Coll Cardiol. 1983;1:783–789. doi: 10.1016/S0735-1097(83)80191-0.
    1. Tuseth N, Cramariuc D, Rieck AE, Wachtell K, Gerdts E. Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy) Blood Press. 2010;19:140–144. doi: 10.3109/08037051.2010.481816.
    1. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220–228. doi: 10.1016/j.jacc.2009.05.006.
    1. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension. 2002;39:750–755. doi: 10.1161/hy0302.104674.
    1. John AS, Dill T, Brandt RR, Rau M, Ricken W, Bachmann G, Hamm CW. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol. 2003;42:519–526. doi: 10.1016/S0735-1097(03)00707-1.
    1. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006;8:417–426. doi: 10.1080/10976640600572889.
    1. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–542. doi: 10.1161/hc0402.102975.
    1. Rodriguez CJ, Diez-Roux AV, Moran A, Jin Z, Kronmal RA, Lima J, Homma S, Bluemke DA, Barr RG. Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis) J Am Coll Cardiol. 2010;55:234–242. doi: 10.1016/j.jacc.2009.08.046.
    1. Buchner S, Debl K, Haimerl J, Djavidani B, Poschenrieder F, Feuerbach S, Riegger GA, Luchner A. Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2009;11:18. doi: 10.1186/1532-429X-11-18.
    1. Lamb HJ, Beyerbacht HP, de Roos A, van der Laarse A, Vliegen HW, Leujes F, Bax JJ, van der Wall EE. Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. J Am Coll Cardiol. 2002;40:2182–2188. doi: 10.1016/S0735-1097(02)02604-9.
    1. Salcedo EE, Korzick DH, Currie PJ, Stewart WJ, Lever HM, Goormastic M. Determinants of left ventricular hypertrophy in patients with aortic stenosis. Cleve Clin J Med. 1989;56:590–596.
    1. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J. 2005;26:1790–1796. doi: 10.1093/eurheartj/ehi290.
    1. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679–688. doi: 10.1161/01.CIR.59.4.679.
    1. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–1785. doi: 10.1056/NEJM200006153422403.
    1. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, Banya W, Gulati A, Roussin I, Raza S. et al.Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58:1271–1279. doi: 10.1016/j.jacc.2011.03.064.
    1. Orlowska-Baranowska E, Placha G, Gaciong Z, Baranowski R, Zakrzewski D, Michalek P, Hoffman P, Rawczynska-Englert I. Influence of ACE I/D genotypes on left ventricular hypertrophy in aortic stenosis: gender-related differences. J Heart Valve Dis. 2004;13:574–581.
    1. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992;86:1099–1107. doi: 10.1161/01.CIR.86.4.1099.
    1. Rieck AE, Cramariuc D, Staal EM, Rossebo AB, Wachtell K, Gerdts E. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy) J Hypertens. 2010;28:377–383. doi: 10.1097/HJH.0b013e328332fa44.
    1. Montgomery HE, Clarkson P, Dollery C, Prasad K, Losi MA. Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training. Circulation. 1997;96:741–747. doi: 10.1161/01.CIR.96.3.741.
    1. Marian AJ. Genetic determinants of cardiac hypertrophy. Curr Opin Cardiol. 2008;115:199–205.
    1. Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, Mangion J, Schroen B, Benson M, Punjabi PP. et al.Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet. 2008;40:546–552. doi: 10.1038/ng.134.
    1. Dellgren G, Eriksson MJ, Blange I, Brodin LA, Radegran K, Sylven C. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol. 1999;84:909–913. doi: 10.1016/S0002-9149(99)00464-6.
    1. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H. et al.ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;2011(58):e212–e260.
    1. Yokota Y, Teng SS, Emoto R, Miki T, Takarada A, Seo T, Sano H, Fukuzaki H. Mechanism of development of asymmetric septal hypertrophy in patients with essential systemic hypertension. Jpn Circ J. 1989;53:1173–1184. doi: 10.1253/jcj.53.1173.
    1. Lund O, Flo C, Jensen FT, Emmertsen K, Nielsen TT, Rasmussen BS, Hansen OK, Pilegaard HK, Kristensen LH. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J. 1997;18:1977–1987. doi: 10.1093/oxfordjournals.eurheartj.a015209.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi